RxDoctor Payments Data

John Molina, DO

Family Medicine · Riverside, CANPI 1770547523

Payments from drug & device makers

$286in general payments, 2019–2025

Across 17 payments — averaging $16.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$83
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$43
  • Abbott$30
  • AstraZeneca$26
  • Novartis$24
  • Lilly USA, LLC$23
  • plus $55 from 3 others

What the payments were for

  • Food & beverage$286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$286 in reported general payments places this provider in the 50th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$102,321
Medicare patients
97
Services billed
1,377

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin38$52,652
OzempicSemaglutide41$47,437
EliquisApixaban55$46,644
XareltoRivaroxaban21$28,757
LinzessLinaclotide15$11,492
JanumetSitagliptin Phos/Metformin Hcl18$11,188
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog26$10,955
SynjardyEmpagliflozin/Metformin Hcl13$8,628
Lantus SolostarInsulin Glargine,hum.Rec.Anlog52$6,402
Valsartan286$5,085
Rosuvastatin Calcium275$3,298
LantusInsulin Glargine,hum.Rec.Anlog25$3,108
Lubiprostone29$2,772
Levothyroxine Sodium192$2,380
Insulin Lispro Kwikpen U-100Insulin Lispro16$2,287

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$83$28,75721 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 10,533 family medicine providers in California.

Other family medicine in Riverside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →